ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.
- Revenue
- +5.93%
- EPS
- +23.1%
- Free cash flow
- −9.79%
- Total debt
- −38.9%
Quarter to September 2026, against a year earlier
Follow RMD
Alert me
ResMed Inc. (RMD) Debt to equity
ResMed Inc.'s debt to equity at the end of the quarter to 30 September 2026 was 0.0×, down 0.0× from fiscal 2026 (0.1×). Over the past ten years it has ranged from 0.1× (fiscal 2026) to 0.6× (fiscal 2019) — the current reading is the lowest in ten years. That is below the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2026 | 0.1× | (44.97%) |
| FY2025 | 0.1× | (23.08%) |
| FY2024 | 0.1× | (58.63%) |
| FY2023 | 0.3× | 52.22% |
| FY2022 | 0.2× | 2.15% |
| FY2021 | 0.2× | (52.19%) |
| FY2020 | 0.5× | (23.26%) |
| FY2019 | 0.6× | 363.39% |
| FY2018 | 0.1× | (76.17%) |
| FY2017 | 0.6× | 6.77% |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | 0.0× | (30.81%) |
| Jun 2026 | 0.1× | (2.57%) |
| Mar 2026 | 0.1× | (2.50%) |
| Dec 2025 | 0.1× | (4.34%) |
| 43 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| ALGN Align Technology, Inc. compare | 0.0× |
| RMD ResMed Inc. | 0.0× |
| WST West Pharmaceutical Services, Inc. compare | 0.1× |
| SOLV Solventum Corporation compare | 0.1× |
| ALC Alcon compare | 0.2× |
| COO The Cooper Companies, Inc. compare | 0.3× |
| BDX Becton, Dickinson and Company compare | 0.6× |
| MDLN Medline Inc. compare | 0.6× |
| BAX Baxter International Inc. compare | 1.3× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement